author_facet Dejanov, Petar
Dejanova, Beti
Dejanov, Petar
Dejanova, Beti
author Dejanov, Petar
Dejanova, Beti
spellingShingle Dejanov, Petar
Dejanova, Beti
Serbian Journal of Experimental and Clinical Research
Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
General Medicine
author_sort dejanov, petar
spelling Dejanov, Petar Dejanova, Beti 1820-8665 2335-075X Walter de Gruyter GmbH General Medicine http://dx.doi.org/10.1515/sjecr-2015-0037 <jats:title>Abstract</jats:title><jats:p>The appropriate biomarkers for oxidative stress (OS) in patients with end stage renal disease (ESRD) are important in renal pathology. Patients (56) with ESRD were investigated (35 men and 21 women). Patients, with mean age of 45±17 years, defined education, specific HD duration and calculated body mass index (BMI), were exposed to a polysulphone type HD membrane for approximately 4 hours per HD session, 3 times per week. The control group was composed of 31 healthy volunteers. The total antioxidative capacity (TAC) and the antioxidative (AO) enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx), were assessed. Analyses included Randox Crumlin GB; lipid peroxidation (LP) using its end product, malonyldialdehyde (MDA) (fluorimetric); and a LDL-ox immunoassay (Biomedica gruppe, Vienna, Austria). The TAS was higher in ESRD patients before HD (1.63±0.1 mmol/L) compared to the control group (1.23±0.03 mmol/L).</jats:p> Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease Serbian Journal of Experimental and Clinical Research
doi_str_mv 10.1515/sjecr-2015-0037
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUxNS9zamVjci0yMDE1LTAwMzc
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUxNS9zamVjci0yMDE1LTAwMzc
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint Walter de Gruyter GmbH, 2015
imprint_str_mv Walter de Gruyter GmbH, 2015
issn 1820-8665
2335-075X
issn_str_mv 1820-8665
2335-075X
language Undetermined
mega_collection Walter de Gruyter GmbH (CrossRef)
match_str dejanov2015appropriatebiomarkersforoxidativestressinpatientswithendstagerenaldisease
publishDateSort 2015
publisher Walter de Gruyter GmbH
recordtype ai
record_format ai
series Serbian Journal of Experimental and Clinical Research
source_id 49
title Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_unstemmed Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_full Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_fullStr Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_full_unstemmed Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_short Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_sort appropriate biomarkers for oxidative stress in patients with end stage renal disease
topic General Medicine
url http://dx.doi.org/10.1515/sjecr-2015-0037
publishDate 2015
physical 287-290
description <jats:title>Abstract</jats:title><jats:p>The appropriate biomarkers for oxidative stress (OS) in patients with end stage renal disease (ESRD) are important in renal pathology. Patients (56) with ESRD were investigated (35 men and 21 women). Patients, with mean age of 45±17 years, defined education, specific HD duration and calculated body mass index (BMI), were exposed to a polysulphone type HD membrane for approximately 4 hours per HD session, 3 times per week. The control group was composed of 31 healthy volunteers. The total antioxidative capacity (TAC) and the antioxidative (AO) enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx), were assessed. Analyses included Randox Crumlin GB; lipid peroxidation (LP) using its end product, malonyldialdehyde (MDA) (fluorimetric); and a LDL-ox immunoassay (Biomedica gruppe, Vienna, Austria). The TAS was higher in ESRD patients before HD (1.63±0.1 mmol/L) compared to the control group (1.23±0.03 mmol/L).</jats:p>
container_issue 4
container_start_page 287
container_title Serbian Journal of Experimental and Clinical Research
container_volume 16
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792322037022195713
geogr_code not assigned
last_indexed 2024-03-01T11:11:31.758Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Appropriate+Biomarkers+For+Oxidative+Stress+In+Patients+With+End+Stage+Renal+Disease&rft.date=2015-12-01&genre=article&issn=2335-075X&volume=16&issue=4&spage=287&epage=290&pages=287-290&jtitle=Serbian+Journal+of+Experimental+and+Clinical+Research&atitle=Appropriate+Biomarkers+For+Oxidative+Stress+In+Patients+With+End+Stage+Renal+Disease&aulast=Dejanova&aufirst=Beti&rft_id=info%3Adoi%2F10.1515%2Fsjecr-2015-0037&rft.language%5B0%5D=und
SOLR
_version_ 1792322037022195713
author Dejanov, Petar, Dejanova, Beti
author_facet Dejanov, Petar, Dejanova, Beti, Dejanov, Petar, Dejanova, Beti
author_sort dejanov, petar
container_issue 4
container_start_page 287
container_title Serbian Journal of Experimental and Clinical Research
container_volume 16
description <jats:title>Abstract</jats:title><jats:p>The appropriate biomarkers for oxidative stress (OS) in patients with end stage renal disease (ESRD) are important in renal pathology. Patients (56) with ESRD were investigated (35 men and 21 women). Patients, with mean age of 45±17 years, defined education, specific HD duration and calculated body mass index (BMI), were exposed to a polysulphone type HD membrane for approximately 4 hours per HD session, 3 times per week. The control group was composed of 31 healthy volunteers. The total antioxidative capacity (TAC) and the antioxidative (AO) enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx), were assessed. Analyses included Randox Crumlin GB; lipid peroxidation (LP) using its end product, malonyldialdehyde (MDA) (fluorimetric); and a LDL-ox immunoassay (Biomedica gruppe, Vienna, Austria). The TAS was higher in ESRD patients before HD (1.63±0.1 mmol/L) compared to the control group (1.23±0.03 mmol/L).</jats:p>
doi_str_mv 10.1515/sjecr-2015-0037
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUxNS9zamVjci0yMDE1LTAwMzc
imprint Walter de Gruyter GmbH, 2015
imprint_str_mv Walter de Gruyter GmbH, 2015
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 1820-8665, 2335-075X
issn_str_mv 1820-8665, 2335-075X
language Undetermined
last_indexed 2024-03-01T11:11:31.758Z
match_str dejanov2015appropriatebiomarkersforoxidativestressinpatientswithendstagerenaldisease
mega_collection Walter de Gruyter GmbH (CrossRef)
physical 287-290
publishDate 2015
publishDateSort 2015
publisher Walter de Gruyter GmbH
record_format ai
recordtype ai
series Serbian Journal of Experimental and Clinical Research
source_id 49
spelling Dejanov, Petar Dejanova, Beti 1820-8665 2335-075X Walter de Gruyter GmbH General Medicine http://dx.doi.org/10.1515/sjecr-2015-0037 <jats:title>Abstract</jats:title><jats:p>The appropriate biomarkers for oxidative stress (OS) in patients with end stage renal disease (ESRD) are important in renal pathology. Patients (56) with ESRD were investigated (35 men and 21 women). Patients, with mean age of 45±17 years, defined education, specific HD duration and calculated body mass index (BMI), were exposed to a polysulphone type HD membrane for approximately 4 hours per HD session, 3 times per week. The control group was composed of 31 healthy volunteers. The total antioxidative capacity (TAC) and the antioxidative (AO) enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx), were assessed. Analyses included Randox Crumlin GB; lipid peroxidation (LP) using its end product, malonyldialdehyde (MDA) (fluorimetric); and a LDL-ox immunoassay (Biomedica gruppe, Vienna, Austria). The TAS was higher in ESRD patients before HD (1.63±0.1 mmol/L) compared to the control group (1.23±0.03 mmol/L).</jats:p> Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease Serbian Journal of Experimental and Clinical Research
spellingShingle Dejanov, Petar, Dejanova, Beti, Serbian Journal of Experimental and Clinical Research, Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease, General Medicine
title Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_full Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_fullStr Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_full_unstemmed Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_short Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
title_sort appropriate biomarkers for oxidative stress in patients with end stage renal disease
title_unstemmed Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
topic General Medicine
url http://dx.doi.org/10.1515/sjecr-2015-0037